Literature DB >> 25354866

Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

Leah M Iles1, Andris H Ellims2, Huw Llewellyn3, James L Hare2, David M Kaye2, Catriona A McLean3, Andrew J Taylor2.   

Abstract

AIM: Myocardial fibrosis is fundamental in the pathogenesis of heart failure. Late gadolinium enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is commonly assumed to represent myocardial fibrosis; however, comparative human histological data are limited, especially in non-ischaemic cardiac disease. Diffuse interstitial myocardial fibrosis is increasingly recognized as central in the pathogenesis of cardiomyopathy and can be quantified using newer CMR techniques such as T1 mapping. We evaluated the relationship of CMR assessment of regional and diffuse fibrosis with human histology. METHODS AND
RESULTS: Eleven patients on the waiting list for heart transplantation (43.5 ± 7.6 years, 64% male) and eight patients undergoing surgical myectomy for obstructive hypertrophic cardiomyopathy (57.1 ± 8.6 years, 63% male) were recruited and underwent CMR prior to cardiac transplantation or myectomy. Quantification of fibrosis in explanted hearts using digitally analysed Masson-trichrome-stained slides was validated against picrosirius red-stained slides analysed using Image J, with an excellent correlation (R = 0.95, P < 0.0001). Significant correlations were observed between LGE and histological fibrosis across a range of signal intensity thresholds in the explanted hearts (range: 2-10 standard deviations above reference myocardium), with maximal accuracy at a threshold of 6 SD (R = 0.91, P < 0.001). Assessment of interstitial myocardial fibrosis with post-contrast T1 times demonstrated a significant correlation on both segmental (R = -0.64, P = 0.002) and per-patient (R = -0.78, P = 0.003) analyses.
CONCLUSION: CMR provides accurate, non-invasive assessment of regional myocardial fibrosis using LGE, while diffuse interstitial myocardial fibrosis is accurately assessed with post-contrast T1 mapping. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiomyopathy; Magnetic resonance imaging; Pathology; myocardial fibrosis

Mesh:

Substances:

Year:  2014        PMID: 25354866     DOI: 10.1093/ehjci/jeu182

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  63 in total

1.  Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.

Authors:  Gaetano Nucifora; Daniele Muser; Pasquale Gianfagna; Giorgio Morocutti; Alessandro Proclemer
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-26       Impact factor: 2.357

2.  Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Teppei Fujita; Yuichiro Iida; Takeru Nabeta; Shunsuke Ishii; Emi Maekawa; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Junya Ako
Journal:  Heart Vessels       Date:  2016-02-03       Impact factor: 2.037

3.  MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.

Authors:  Jing Xu; Baiyan Zhuang; Arlene Sirajuddin; Shuang Li; Jinghan Huang; Gang Yin; Lei Song; Yong Jiang; Shihua Zhao; Minjie Lu
Journal:  Radiology       Date:  2019-11-26       Impact factor: 11.105

4.  Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.

Authors:  Mai Azuma; Shingo Kato; Ryusuke Sekii; Sho Kodama; Kei Kinoshita; Keisuke Suzurikawa; Minako Kagimoto; Naoki Nakayama; Kohei Iguchi; Kazuki Fukui; Tae Iwasawa; Daisuke Utsunomiya; Kazuo Kimura; Kouichi Tamura
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 2.357

Review 5.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.

Authors:  Katherine C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792

6.  Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.

Authors:  Anna Axelsson Raja; Hoshang Farhad; Anne Marie Valente; John-Paul Couce; John Lynn Jefferies; Henning Bundgaard; Kenneth Zahka; Harry Lever; Anne M Murphy; Euan Ashley; Sharlene M Day; Mark V Sherrid; Ling Shi; David A Bluemke; Charles E Canter; Steven D Colan; Carolyn Y Ho
Journal:  Circulation       Date:  2018-08-21       Impact factor: 29.690

Review 7.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

8.  Myocardial native-T1 times are elevated as a function of hypertrophy, HbA1c, and heart rate in diabetic adults without diffuse fibrosis.

Authors:  Bonnie Lam; Tori A Stromp; Zhengxiong Hui; Moriel Vandsburger
Journal:  Magn Reson Imaging       Date:  2019-05-21       Impact factor: 2.546

Review 9.  Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations.

Authors:  Mabel Toribio; Tomas G Neilan; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

Review 10.  Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Authors:  Andrea Barison; Chrysanthos Grigoratos; Giancarlo Todiere; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.